Explore the full record of transactions filed by Schaub James, Dirigeant. Insider active across 3 companies, notably Osmotica Pharmaceuticals plc. Aggregated, 7 reports have been published. Total volume traded: €178k. The latest transaction was disclosed on 18 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
James Schaub is the Executive Vice President and Chief Operating Officer at Osmotica Pharmaceuticals plc. In this role, he oversees the strategic operations and overall direction of the company. Schaub brings valuable expertise in operations management, contributing to optimizing Osmotica's performance. His leadership is essential for achieving the company's operational objectives.